Search by name: ABCDEFGHIJKLMNOPQRSTUVWXYZ

Strategic Partnerships

Ambit’s strategy includes corporate partnerships with the purpose to develop best kinase inhibitors for the treatment of oncologic diseases. Ambit’s partnering strategy includes three components:

  • Oncology drugs;
  • Non-oncology drugs;
  • Collaborative research.

If you want to become a strategic partner of Ambit, please contact us immediately.